A randomized controlled trial of presatovir for respiratory syncytial virus after lung transplant.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation（2023）
摘要
Presatovir treatment did not significantly improve change in nasal RSV load, symptoms, or lung function in lung transplant recipients.
更多查看译文
关键词
RSV fusion inhibitor,lung transplant,presatovir,randomized controlled trial,respiratory syncytial virus
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要